MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China — August 9, 2010 — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June 30, 2010. Highlights for Second Quarter and First Half 2010 — Net revenues were]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2010 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China — August 9, 2010 — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June 30, 2010. Highlights for Second Quarter and First Half 2010 — Net revenues were]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June30, 2010. Highlights for Second Quarter and First Half 2010]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2010 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June30, 2010. Highlights for Second Quarter and First Half 2010]

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [EX-3.1 2 cphi10qex31063010.htm AMENDED AND RESTATED CHARTER] [EMPLOYMENT AGREEMENT April 28 Agreement Company nd Employee XXX XX XXXX Parties This EMPLOYMENT AGREEMENT is made and entered into as of WITNESSETH: WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable his] [CHINA PHARMA HOLDINGS, INC. 2010 SHARES OPTION AGREEMENT China Pharma Holdings, Inc., Frank Waung This 2010 Shares Option Agreement (the “Agreement”) is made as of April 28, 2010 between 1. Notice of Shares Option Grant You (the “Optionee”) have been granted an option to subscribe for, acquire and purchase common shares in the Company (the “Common Shares”), subject to the] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 -------------------------------- President and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 --------------------- (principal financial officer and principal accounting officer)]

By | 2016-03-03T20:17:15+00:00 August 9th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x June 30, 2010

[FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [EX-3.1 2 cphi10qex31063010.htm AMENDED AND RESTATED CHARTER] [EMPLOYMENT AGREEMENT April 28 Agreement Company nd Employee XXX XX XXXX Parties This EMPLOYMENT AGREEMENT is made and entered into as of WITNESSETH: WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable his] [CHINA PHARMA HOLDINGS, INC. 2010 SHARES OPTION AGREEMENT China Pharma Holdings, Inc., Frank Waung This 2010 Shares Option Agreement (the “Agreement”) is made as of April 28, 2010 between 1. Notice of Shares Option Grant You (the “Optionee”) have been granted an option to subscribe for, acquire and purchase common shares in the Company (the “Common Shares”), subject to the] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 -------------------------------- President and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 --------------------- (principal financial officer and principal accounting officer)]

By | 2016-03-03T20:19:11+00:00 August 9th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

HSOL [Hanwha Q CELLS] 6-K: (Original Filing)

["I am excited to have Mr. Miller and Mr. Landry on our team," said Bruce Ludemann, VP and General Manager for Solarfun North America. "Their addition to our marketing and customer support team is an important part of our growth strategy in the U.S. market, and apart from being seasoned business development veterans, Mr. Miller's and Mr. Landry's regional knowledge] [99.1 Press Release Dated August 9, 2010. SOLARFUN POWER HOLDINGS CO., LTD]

By | 2016-03-15T09:21:22+00:00 August 9th, 2010|Categories: Chinese Stocks, HSOL, SEC Original|Tags: , , , , , |0 Comments

CXDC [China XD Plastics Co] 10-Q: (Original Filing)

[CHINA XD PLASTICS COMPANY LIMITED Index PART I— FINANCIAL INFORMATION Page Item 1. Financial Statements 2 Condensed Consolidated Financial Statements (Unaudited) 2 Notes to the Condensed Consolidated Financial Statements (Unaudited) 5 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 37 Item 3. Quantitative and Qualitative Disclosures About Market Risk 44 Item 4T. Controls and Procedures] [入区协议 District Entry Agreement 甲方:哈尔滨经济技术开发区管理委员会 Party A: Harbin Economic and Technological Development Zone Administration 乙方:哈尔滨鑫达高分子材料有限责任公司 Party B: Harbin Xinda Macromolecule Material Co., Ltd. 甲方为支持乙方发展,就企业经营地址迁入哈尔滨经济技术开发区相关事宜及所给予的优惠政策达成如下协议: To support the development of Party B, the business moved to Harbin Economic and Technological Development Zone, address related issues and the preferential policies granted by the agreement reached as follows: 第一条 Article I Committed to] [I, Jie Han, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification of Principal Financial Officer I, Taylor Zhang, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Taylor Zhang, Principal Financial and Accounting Officer]

By | 2016-03-25T18:04:57+00:00 August 9th, 2010|Categories: Chinese Stocks, CXDC, SEC Original|Tags: , , , , , |0 Comments

HSOL [Hanwha Q CELLS] 6-K: “I am excited to have Mr. Miller and

["I am excited to have Mr. Miller and Mr. Landry on our team," said Bruce Ludemann, VP and General Manager for Solarfun North America. "Their addition to our marketing and customer support team is an important part of our growth strategy in the U.S. market, and apart from being seasoned business development veterans, Mr. Miller's and Mr. Landry's regional knowledge] [99.1 Press Release Dated August 9, 2010. SOLARFUN POWER HOLDINGS CO., LTD]

By | 2016-03-15T09:23:22+00:00 August 9th, 2010|Categories: Chinese Stocks, HSOL, Webplus ver|Tags: , , , , , |0 Comments

CXDC [China XD Plastics Co] 10-Q: CHINA XD PLASTICS COMPANY LIMITED Index PART I—

[CHINA XD PLASTICS COMPANY LIMITED Index PART I— FINANCIAL INFORMATION Page Item 1. Financial Statements 2 Condensed Consolidated Financial Statements (Unaudited) 2 Notes to the Condensed Consolidated Financial Statements (Unaudited) 5 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 37 Item 3. Quantitative and Qualitative Disclosures About Market Risk 44 Item 4T. Controls and Procedures] [入区协议 District Entry Agreement 甲方:哈尔滨经济技术开发区管理委员会 Party A: Harbin Economic and Technological Development Zone Administration 乙方:哈尔滨鑫达高分子材料有限责任公司 Party B: Harbin Xinda Macromolecule Material Co., Ltd. 甲方为支持乙方发展,就企业经营地址迁入哈尔滨经济技术开发区相关事宜及所给予的优惠政策达成如下协议: To support the development of Party B, the business moved to Harbin Economic and Technological Development Zone, address related issues and the preferential policies granted by the agreement reached as follows: 第一条 Article I Committed to] [I, Jie Han, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification of Principal Financial Officer I, Taylor Zhang, certify that: 1. I have reviewed this report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Taylor Zhang, Principal Financial and Accounting Officer]

By | 2016-03-25T18:05:50+00:00 August 9th, 2010|Categories: Chinese Stocks, CXDC, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar